WNT5A and osteosarcoma: The observed anti-apoptotic effect of FHL2 silencing in osteosarcoma cells may be linked in part to the observed decrease in Wnt5a, since this protein exerts anti-apoptotic activity in cells of the osteoblast lineage [44].